Dr. Nathan Price is Chief Scientific Officer of Thorne HealthTech (NASDAQ: THRN). Previously he was CEO of Onegevity, an AI health intelligence company that merged with Thorne prior to the IPO in 2021. In 2019, he was named as one of the 10 Emerging Leaders in Health and Medicine by the National Academy of Medicine, and in 2021 he was appointed to the Board on Life Sciences of the National Academies of Sciences, Engineering, and Medicine. He spent much of his earlier career as Professor and Associate Director of the Institute for Systems Biology (now on leave), co-director with biotechnology pioneer Lee Hood of the Hood-Price Lab for Systems Biomedicine, and is Affiliate Faculty at the University of Washington in Bioengineering and Computer Science & Engineering. He is a Camille Dreyfus Teacher-Scholar, received the 2016 Grace A. Goldsmith award for his work pioneering 'scientific wellness', was a co-founder of Arivale, and received a Healthy Longevity Catalyst Award from the National Academy of Medicine in 2020. He has co-authored more than 180 peer-reviewed scientific publications and given over 200 talks and keynotes. He also served as Chair of the NIH Study Section on Modeling and Analysis of Biological Systems (MABS).
Kevin Perrott is a successful businessman and owner of a large snowmobile and motorcycle dealership in Canada. After becoming a cancer survivor he decided to focus his efforts on the study of age-related disease and obtained a Ph.D. for work studying natural compounds effects on the inflammation produced by senescent cells in the lab of Judith Campisi at the Buck Institute for Research on Aging. He is Treasurer and co-founder of SENS Research Foundation and former Director of the Methuselah Foundation. He also cofounded Oisin Biotechnologies, a for-profit fighting aging through 'reprogramming' biology. After years of working in both the for-profit and non-profit sectors to accelerate the development of interventions in aging, it became clear that a large reason for the delay is lack of involvement of the consumer and he became the Founder and CEO of OpenCures, a for-benefit enterprise that has created a platform that enables collaboration and synergies between customers and the companies who develop health technologies.
Dr. Ronjon Nag is an inventor and entrepreneur. He is a founder and advisor/board member of multiple start-ups. His companies have been sold to Apple, BlackBerry, and Motorola. He has been awarded the Mountbatten Medal in the Royal Institution by the Institution of Engineering and Technology and has been the winner (Bounce Imaging-Board) of the $1m Verizon Powerful Answers Award. He has been a pioneer of smartphones and the 'app stores' they depend on.
He has worked on neural networks, touch screens, mobile search, voice recognition, text prediction, and handwriting recognition. He has a Ph.D. from Cambridge, an M.S from M.I.T, and a B.Sc. from Birmingham in the UK. Additionally, he is a Stanford Distinguished Careers Institute Interdisciplinary Fellow based at the Stanford Center for Language and Information (CSLI).
Fascinated from a young age by how a single cell forms the whole human body following an innate genetic program, Jean M. Hébert became driven by how knowledge of this process might be used to improve our biological fates and defeat aging. To this end, he first trained as a molecular geneticist, obtaining his Ph.D. from the University of California, San Francisco, before specializing in the study of how neural stem cells form the brain at Stanford University. He is now a Professor of Neuroscience and Genetics at the Albert Einstein College of Medicine in New York, where he is developing ways to use cell and tissue replacements to repair and rejuvenate the brain.
Professor de Magalhaes graduated in Microbiology in 1999 from the Escola Superior de Biotecnologia in his hometown of Porto, Portugal, and then obtained his Ph.D. in 2004 from the University of Namur in Belgium. Following a postdoc with genomics pioneer Prof George Church at Harvard Medical School, in 2008 Prof de Magalhaes was recruited to the University of Liverpool. He now leads the Integrative Genomics of Ageing Group which focuses on understanding the genetic, cellular, and molecular mechanisms of aging. Professor de Magalhaes has authored over 100 publications and given over 100 invited talks, including three TEDx talks. He is also Chief Scientific Officer of Swiss-based biotech Centaura. His ultimate goal is to develop interventions that preserve health and fend off age-related diseases by manipulating the aging process.
He is the founder and currently the president of the Swiss Society for Aging Research (www.ssfar.ch). He has received multiple awards, including NYAS Future Entrepreneur recognized by the New York Academy of Sciences, and is named under the top 1000 Longevity Leaders worldwide and the top 15 Longevity Influencers in Switzerland.
Research interests: Our recent work has shown that many health- and longevity-promoting interventions re-activate the expression of extracellular matrix (ECM) genes during aging (Ewald et al., Nature 2015, PMID:25517099). This ECM enhancement is required and sufficient for extending the lifespan of C. elegans. Our research efforts are focusing on exploring the mechanism(s) of how prolonged ECM homeostasis promotes healthy aging.
Expertise: C. elegans ECM, aging, protein aggregation, neurodegeneration (Alzheimer's disease), Insulin/IGF-1 signaling, NADPH oxidases, ROS, oxidative stress, automated lifespan assessment, genetic and chemical high-throughput screening.
Lab website: http://ewaldlab.com
Ravi Bala is an AgeTech Evangelist and a startup mentor in AgeTech and Remote Monitoring. He is a Co-Founder and former Board Member at HealthSignals, LLC, a leader in technology solutions for better senior living. An innovator and an expert in mobile health and digital strategy, he has a successful track record of creating and managing teams of independent thinkers. He has a tenacious dedication to compassion and dignity in the workplace. He is a teacher, a mentor, and a coach at heart and works with many startup ventures as an advisor.
He is currently Chair of the Capital for Good and board member for Girls First Fund – a global effort to end child marriage and is on the Advisory Board of CyberSeniors and the SeniorTrade Blog. He is also a mentor with the Silver Moonshots accelerator and a member of the Drexel University AgeWell Collaboratory. He has taught courses in Digital Strategy in multiple MBA programs in Philadelphia. His latest passion is changing the model of eldercare with the aid of Conversational AI, Robotics and Passive Monitoring.
He obtained an M.Sc. (2013) in Quantitative Finance from London Business School, and a BA (Hon) from the University of Toronto in Economics, Statistics, and Theology.
Cumulative experience of 12 years in Healthcare & Life sciences
· Healthcare innovations: Biotech, Digital Health, MedTech, Wellness
· Portfolio management & strategy
· Building partnerships and strategic initiatives
· Business and domain consultancy
Nikolina is a successful serial entrepreneur, CEO, and co-founder of GlycanAge. GlycanAge was founded on a promise that "health care" should start with us caring about our health before we encounter a particular problem.GlycanAge allows you to measure & influence your longevity by looking at an entirely new part of biology. Glycan biomarkers uniquely encapsulate genetic, epigenetic, and environmental factors driving longevity for every human.
Allison Duettmann is the president of Foresight Institute. She leads the Intelligent Cooperation, Molecular Machines, Biotech & Health Extension Groups, shares Foresight's work with the public, e.g. at the Wall Street Journal, SXSW, O'Reilly AI, WEF, The Partnership on AI, Effective Altruism Global, TEDx.She co-edited the book Superintelligence: Coordination & Strategy, and is collaborating on another book on Intelligent Voluntary Cooperation. She holds an MS in Philosophy & Public Policy from the London School of Economics, focusing on AI Safety, and a BA in Philosophy, Politics, Economics from York University.
"WE CANNOT TEACH PEOPLE ANYTHING; WE CAN ONLY HELP THEM DISCOVER IT WITHIN THEMSELVES."